These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7084817)

  • 1. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
    Hiyama T; Shintani S; Tsutsui M; Yasuda Y
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions between buprenorphine, narcotic analgesic, and centrally acting drugs in prolongation of halothane-induced sleeping and analgesia (author's transl)].
    Yasuda Y; Shioya Y; Nakai S; Shintani S; Hiyama T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):163-72. PubMed ID: 6123474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroencephalographic study of pentazocine and buprenorphine.
    Kubicki S; Azcona A
    Acta Anaesthesiol Belg; 1979; 30 Suppl():123-33. PubMed ID: 547656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological properties of buprenorphine, a new analgesic agent. Part II. (author's transl)].
    Shintani S; Umezato M; Toba Y; Yamaji Y; Kitaura K; Tani T; Ishiyama H; Kikuchi T; Mori T; Nakai S; Watanabe K; Hiyama T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):173-91. PubMed ID: 6123475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study about the analgesic effect of buprenorphine (author's transl)].
    Rigolot JC; Vergnes Y; Bouket JL; Gauthier-Lafaye P
    Anesth Analg (Paris); 1979; 36(7-8):317-21. PubMed ID: 525837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of analgesic effects of morphine, buprenorphine and pentazocine in rats receiving somatic and visceral stimulation].
    Iwasaki H; Ohmori H; Kobayashi I; Omote K; Kawamata M; Namiki A
    Masui; 1994 Nov; 43(11):1648-52. PubMed ID: 7861593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method.
    Gray WD; Osterberg AC; Scuto TJ
    J Pharmacol Exp Ther; 1970 Mar; 172(1):154-62. PubMed ID: 5416940
    [No Abstract]   [Full Text] [Related]  

  • 9. Sites of analgesic action of cyclazocine: a study using evoked-potentials at various regions of the CNS by electrical stimulation of rabbit tooth pulp.
    Foong FW; Satoh M; Takagi H
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):212-8. PubMed ID: 7103611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological actions of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1,H-4-benzazonine). 4. Antagonistic action of naloxone on eptazocine analgesia].
    Nabeshima T; Yamada S; Yamaguchi K; Matsuno K; Kameyama T; Sakakibara S; Matsumoto S
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):411-20. PubMed ID: 6629212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analgesic effect of pentazocine and its action on nociceptive afferent pathway].
    Shima K; Sakurada S; Kisara K
    Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):135-42. PubMed ID: 558943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of multiple analgesic opiate receptors.
    Fürst S; Knoll J
    Int J Tissue React; 1985; 7(1):69-77. PubMed ID: 2861170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
    Shannon HE; Cone EJ; Gorodetzky CW
    J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.
    Cowan A; Lewis JW; Macfarlane IR
    Br J Pharmacol; 1977 Aug; 60(4):537-45. PubMed ID: 409448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flunixin meglumine: a non-narcotic analgesic.
    Ciofalo VB; Latranyi MB; Patel JB; Taber RI
    J Pharmacol Exp Ther; 1977 Mar; 200(3):501-7. PubMed ID: 850126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology of 20681-S and 20682-S, 6-oxo-N-cyclopropylmethylmorphinans, as narcotic antagonist analgesics.
    Hirose K; Matsushita A; Kojima Y; Eigyo M; Jyoyama H; Shiomi T; Tsukinoki Y; Hatakeyama H; Matsubara K; Kawasaki K
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):79-91. PubMed ID: 43119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the discriminative effects of morphine in the rat.
    Shannon HE; Holtzman SG
    J Pharmacol Exp Ther; 1976 Jul; 198(1):54-65. PubMed ID: 6794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
    Kuhn DM; Greenberg I; Appel JB
    J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.